FLGT

Fulgent Genetics, Inc.

48
Fundamentals39/ 100
Valuation50/ 100
Upside potential61/ 100
Risk potential36/ 100

FLGT lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow.

FLGT Fundamentals

MetricStatus
Stable
Weak
Under pressure
Strong

FLGT's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.

FLGT PE Valuation

FLGT has no meaningful PE right now: it lost money over the past year.

FLGT Forward outlook

MetricOutlook
--
Losses growing
Growth
Weakening
Limited
High

Analysts expect FLGT's losses to grow, with revenue growing.

FLGT Risk to reward

ScenarioChangePrice
Upside+55%$38.60
Downside-36%$16.02

Calculated from the latest close: $24.85 on Nov 12.

FLGT's one-year upside scenario is somewhat larger than its downside: +55% against −36%.

FLGT Earnings Per Share

Q4 2023: $-5.63Q1 2024: $-5.56Q2 2024: $-5.47Q3 2024: $-5.51Q4 2024: $-1.41Q1 2025: $-1.33Q2 2025: $-1.66Q3 2025: $-1.39Q4 2025: $-1.97Q1 2026: $-2.40Q2 2026: $-2.83Q3 2026: $-3.10
Q4 2023: $-5.63Q1 2024: $-5.56Q2 2024: $-5.47Q3 2024: $-5.51Q4 2024: $-1.41Q1 2025: $-1.33Q2 2025: $-1.66Q3 2025: $-1.39Q4 2025: $-1.97Q1 2026: $-2.40Q2 2026: $-2.83Q3 2026: $-3.10
QuarterTTM EPSYoY
Q3 2026-$3.10-$1.71
Q2 2026-$2.83-$1.17
Q1 2026-$2.40-$1.07
Q4 2025-$1.97-$0.56
Q3 2025-$1.39+$4.12
Q2 2025-$1.66+$3.81
Q1 2025-$1.33+$4.23
Q4 2024-$1.41+$4.22

FLGT lost $3.10 per share over the past year, and its loss has widened in each of the last four quarters.

FLGT Quarterly Revenue

Q4 2023: $71MQ1 2024: $64MQ2 2024: $71MQ3 2024: $72MQ4 2024: $76MQ1 2025: $73MQ2 2025: $82MQ3 2025: $84MQ4 2025: $83MQ1 2026: $71MQ2 2026: $85MQ3 2026: $90M
Q4 2023: $71MQ1 2024: $64MQ2 2024: $71MQ3 2024: $72MQ4 2024: $76MQ1 2025: $73MQ2 2025: $82MQ3 2025: $84MQ4 2025: $83MQ1 2026: $71MQ2 2026: $85MQ3 2026: $90M
QuarterRevenueYoY
Q3 2026$90.4M+7.5%
Q2 2026$85.4M+4.4%
Q1 2026$71.1M-3.2%
Q4 2025$83.3M+9.3%
Q3 2025$84.1M+17%
Q2 2025$81.8M+15%
Q1 2025$73.5M+14%
Q4 2024$76.2M+8.1%

FLGT's revenue is recovering but still below its 2021 peak: $90M last quarter, up 7.5% from the same quarter a year ago.

FLGT Free Cash Flow

Q4 2023: $12MQ1 2024: $3MQ2 2024: −$9MQ3 2024: −$35MQ4 2024: $21MQ1 2025: −$9MQ2 2025: −$37MQ3 2025: $5MQ4 2025: −$83MQ1 2026: $2MQ2 2026: −$28MQ3 2026: $107M
Q4 2023: $12MQ1 2024: $3MQ2 2024: −$9MQ3 2024: −$35MQ4 2024: $21MQ1 2025: −$9MQ2 2025: −$37MQ3 2025: $5MQ4 2025: −$83MQ1 2026: $2MQ2 2026: −$28MQ3 2026: $107M
QuarterFree cash flowYoY
Q3 2026$107.4M+2025%
Q2 2026-$27.6M+$9.4M
Q1 2026$1.9M+$11M
Q4 2025-$83.1M-491%
Q3 2025$5.1M+$40.1M
Q2 2025-$37M-$28.3M
Q1 2025-$9.1M-385%
Q4 2024$21.2M+80%

FLGT's free cash flow was −$1M over the past year, against −$20M the year before.

FLGT Total Shares

Q4 2023: 30MQ1 2024: 30MQ2 2024: 30MQ3 2024: 30MQ4 2024: 30MQ1 2025: 31MQ2 2025: 31MQ3 2025: 31MQ4 2025: 31MQ1 2026: 31MQ2 2026: 28MQ3 2026: 28M
Q4 2023: 30MQ1 2024: 30MQ2 2024: 30MQ3 2024: 30MQ4 2024: 30MQ1 2025: 31MQ2 2025: 31MQ3 2025: 31MQ4 2025: 31MQ1 2026: 31MQ2 2026: 28MQ3 2026: 28M
PeriodChange %Net change
Quarterly-1.2%-343K shares
1 year-10%-3.1M shares
3 years-7.8%-2.4M shares
5 years-11%-3.5M shares
Available history+48%+9M shares

FLGT has 28M diluted shares, down 10% from a year ago, with $64M in buybacks over the past year.

FLGT Net Leverage

QuarterNet LeverageStatus
Q4 2022-0.4xNet Cash
Q3 2022-0.4xNet Cash
Q2 2022-0.2xNet Cash
Q1 2022-0.6xNet Cash
Q4 2021-0.2xNet Cash
Q3 2021-0.3xNet Cash
Q2 2021-0.1xNet Cash
Q1 2021-0.3xNet Cash

FLGT has more cash than debt.

FLGT Weekly Momentum

MetricValueStatus
RSI64.9Neutral
Stochastic79.5Neutral

FLGT's weekly RSI is 65 (neutral) and its Stochastic is 79 (neutral).

FLGT PE vs Healthcare Sector

MetricFLGTSector medianRelative
PEN/A26x—

FLGT has no meaningful PE right now: it lost money over the past year.

FLGT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$21.814% above
20 week MA$20.621% above
50 week MA$20.522% above
100 week MA$20.422% above
200 week MA$23.74.9% above

FLGT has climbed back above all five of its weekly moving averages, and it's now 4.9% above its 200-week average.

FLGT Yearly ROI

YearStart priceEnd priceROI
2020$13.2$45.8+246%
2021$45.8$100.2+119%
2022$100.2$30.3-70%
2023$30.3$28.9-4.7%
2024$28.9$18.4-36%
2025$18.4$26.7+45%
2026 YTD$26.7$24.9-7%

FLGT's yearly returns have swung widely, from +246% in 2020 to −70% in 2022. It's down 7% so far in 2026.

Give your agent the market.

Get API key